Reference
PHARMAC. Decision to list bedaquiline (Sirturo) and siltuximab (Sylvant) for rare disorders. Internet Document : 12 May 2016. Available from: URL: https://www.pharmac.govt.nz/news/notification-2016-05-12-bedaquiline-siltuximab-rare-disorders/
Rights and permissions
About this article
Cite this article
Bedaquiline and siltuximab to be listed by PHARMAC. PharmacoEcon Outcomes News 753, 35 (2016). https://doi.org/10.1007/s40274-016-3068-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-016-3068-3